Logo

American Heart Association

  35
  0


Final ID:

How does the co-occurence of atrial fibrillation and amyloidosis impact management?

  • Witteles, Ronald  ( STANFORD UNIVERSITY SCHOOL OF MED , Stanford , California , United States )
  • Garcia-pavia, Pablo  ( Hospital Puerta de Hierro , Majadahonda , Spain )
  • Author Disclosures:
    Ronald Witteles: DO have relevant financial relationships ; Advisor:Pfizer:Active (exists now) ; Advisor:Alexion:Past (completed) ; Advisor:BridgeBio:Active (exists now) ; Advisor:Astra Zeneca:Past (completed) ; Advisor:Alnylam:Active (exists now) | Pablo Garcia-Pavia: DO have relevant financial relationships ; Speaker:Pfizer:Active (exists now) ; Consultant:Life Molecular Imaging:Active (exists now) ; Consultant:Kardigan:Active (exists now) ; Consultant:Ionis Pharmaceuticals:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Bridgebio:Active (exists now) ; Consultant:BMS:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Speaker:AstraZeneca:Active (exists now) ; Speaker:Alnylam:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Consultant:Rocket:Active (exists now) ; Consultant:Lexeo:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Managing Arrhythmias in Special Populations

Friday, 11/07/2025 , 02:15PM - 03:30PM

Cardiovascular Seminar

More abstracts on this topic:
You have to be authorized to contact abstract author. Please, Login
Not Available